1. Home
  2. UGRO vs PYPD Comparison

UGRO vs PYPD Comparison

Compare UGRO & PYPD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo urban-gro Inc.

UGRO

urban-gro Inc.

HOLD

Current Price

$20.14

Market Cap

13.2M

ML Signal

HOLD

Logo PolyPid Ltd.

PYPD

PolyPid Ltd.

HOLD

Current Price

$4.24

Market Cap

81.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
UGRO
PYPD
Founded
2014
2008
Country
United States
Israel
Employees
N/A
N/A
Industry
Industrial Specialties
Medical/Dental Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
13.2M
81.7M
IPO Year
2018
2014

Fundamental Metrics

Financial Performance
Metric
UGRO
PYPD
Price
$20.14
$4.24
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$12.00
AVG Volume (30 Days)
11.4M
54.1K
Earning Date
02-17-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$40,008,850.00
N/A
Revenue This Year
$98.41
N/A
Revenue Next Year
$23.34
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.11
$2.33
52 Week High
$39.68
$5.12

Technical Indicators

Market Signals
Indicator
UGRO
PYPD
Relative Strength Index (RSI) 63.51 49.08
Support Level $0.71 $4.14
Resistance Level $39.68 $4.38
Average True Range (ATR) 6.98 0.20
MACD 0.98 0.01
Stochastic Oscillator 48.83 39.69

Price Performance

Historical Comparison
UGRO
PYPD

About UGRO urban-gro Inc.

Urban-gro Inc operated as an integrated professional services and design-build firm offering architectural, engineering, and construction management solutions to the CEA, industrial, healthcare, and other commercial sectors. The company generated revenue by billing employees time on client projects and provided architectural, engineering, systems procurement and integration, and construction design-build solutions with a single point of accountability. For CEA clients, it developed indoor cultivation facilities for specialty crops, including cannabis and produce such as leafy greens, vegetables, herbs, and berries. Its segments included Equipment Systems (commercial horticulture equipment), Services (design-build services), and Construction Design-Build (general contracting).

About PYPD PolyPid Ltd.

PolyPid Ltd is a clinical-stage biopharmaceutical company engaged in the research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the company's proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized drug delivery into the body over extended periods of time with pre-determined release rates thus optimizing drug treatment regimens. BonyPid, PolyPid, Opzifend, Ssisurg, Elyfssi, Baczenssi, Opzifend and Bacyssio are trademarks of the company. The company's product candidate include D-PLEX100 for prevention of SSI in soft tissue and OncoPLEX which can be a potential Intra-tumoral therapy.

Share on Social Networks: